Direct detection of SARS-CoV-2 using non-commercial RT-LAMP reagents on heat-inactivated samples

Alisa Alekseenko,Donal Barrett,Yerma Pareja-Sanchez,Rebecca J. Howard,Emilia Strandback,Henry Ampah-Korsah,Urška Rovšnik,Silvia Zuniga-Veliz,Alexander Klenov,Jayshna Malloo,Shenglong Ye,Xiyang Liu,Björn Reinius,Simon J. Elsässer,Tomas Nyman,Gustaf Sandh,Xiushan Yin,Vicent Pelechano
DOI: https://doi.org/10.1038/s41598-020-80352-8
IF: 4.6
2021-01-19
Scientific Reports
Abstract:Abstract RT-LAMP detection of SARS-CoV-2 has been shown to be a valuable approach to scale up COVID-19 diagnostics and thus contribute to limiting the spread of the disease. Here we present the optimization of highly cost-effective in-house produced enzymes, and we benchmark their performance against commercial alternatives. We explore the compatibility between multiple DNA polymerases with high strand-displacement activity and thermostable reverse transcriptases required for RT-LAMP. We optimize reaction conditions and demonstrate their applicability using both synthetic RNA and clinical patient samples. Finally, we validate the optimized RT-LAMP assay for the detection of SARS-CoV-2 in unextracted heat-inactivated nasopharyngeal samples from 184 patients. We anticipate that optimized and affordable reagents for RT-LAMP will facilitate the expansion of SARS-CoV-2 testing globally, especially in sites and settings where the need for large scale testing cannot be met by commercial alternatives.
multidisciplinary sciences
What problem does this paper attempt to address?